Filter Results:
(1,248)
Show Results For
- All HBS Web
(1,248)
- People (5)
- News (172)
- Research (929)
- Events (6)
- Multimedia (12)
- Faculty Publications (759)
Show Results For
- All HBS Web
(1,248)
- People (5)
- News (172)
- Research (929)
- Events (6)
- Multimedia (12)
- Faculty Publications (759)
- 28 May 2008
- First Look
First Look: May 28, 2008
goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding... View Details
Keywords: Martha Lagace
- 07 Apr 2003
- Research & Ideas
XTV: Xerox’s Attempted Recovery From “Fumbling the Future”
with researchers at PARC. Much of that time was occupied with interviewing prospective customers who had significant problems with document management. For example, a pharmaceutical company that was applying for FDA approval had to manage... View Details
Keywords: by Henry Chesbrough
- 01 Sep 2014
- News
All For One
industries as diverse as automobiles and pharmaceuticals and began to interview and observe them to see how they created environments ripe for innovation. “We didn’t want to just espouse platitudes,” Hill says. “We wanted to tell full... View Details
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
opposed. Which path should ZappRx take? The case is a window into the early go-to-market and business model decisions that an entrepreneur must make, in this case in the face of pushback from her own management team. The case also provides a detailed picture of the... View Details
Keywords: Sean Silverthorne
- 12 Jan 2010
- First Look
First Look: Jan. 12
and illustrates, via a detailed description of the successful strategic alliance between Solvay Pharmaceuticals Inc. and Quintiles company how the creation of a strategy map and Balanced Scorecard helps align the separate interests of... View Details
Keywords: Martha Lagace
- 19 Aug 2024
- News
Quantum Leap
with one another, making it far easier to do everything from discovering new medicines to designing better batteries. The pharmaceutical and chemical industries have taken note: The venture capital arm of the pharma giant Merck, for... View Details
- 26 Jan 2009
- Research & Ideas
Where is Home for the Global Firm?
you share these ideas? A: Of course, once you write something like this, you come to see many things through these lenses. As reported in the Financial Times in October, several UK firms including Shire Pharmaceuticals and WPP Group have... View Details
Keywords: by Martha Lagace
- 01 Feb 2000
- News
Executives Convene to Discuss Consumer-Driven Health Care
alumni event attracted more than sixty HBS graduates representing biotechnology, e-commerce, managed care, and pharmaceutical companies. The program featured briefings from HBS faculty members interested in issues related to health-care... View Details
- 12 Nov 2013
- First Look
First Look: November 12
GlaxoSmithKline: Sourcing Complex Professional Services Pharmaceutical company GlaxoSmithKline (GSK) uses an innovative new approach to procuring outside legal counsel: it replaces relationship-based selection and law firms' traditional... View Details
Keywords: Sean Silverthorne
- 25 Oct 2004
- Research & Ideas
Planning for Surprises
just two suppliers, while Great Britain has five suppliers to reduce the risk of supply disruptions. While fear of lawsuits has played a role, the fundamental problem is that the economics of vaccine production are unattractive for View Details
Keywords: by Martha Lagace
- 09 Feb 2004
- Research & Ideas
Got a New Strategy? Now Make it Happen
It does so by fitting the organization to the strategy and increasing fitness, the capacity of the organization to learn and change. Since then, this process has been used in more than 150 businesses in the retail, hospitality, high technology, banking, and View Details
Keywords: by Michael Beer & Russell A. Eisenstat
- 2022
- Book
Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]
By: Sabine Pitteloud
En décembre 2020, les Suisses votaient sur l’initiative populaire « pour des multinationales responsables ». Cet épisode récent a rappelé que la régulation de l’activité des sociétés multinationales fait l’objet de luttes politiques, auxquelles participent les... View Details
Keywords: Multinational Enterprise; Multinational Companies; Multinational Corporations; Lobbying; Business & Government Relations; Labor Relations; Relocation; Offshoring And Outsourcing; Corporate Regulation; Transnational Regulation; Multinational Firms and Management; Business and Government Relations; Governing Rules, Regulations, and Reforms; International Relations; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland
Pitteloud, Sabine. Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]. Genève, Suisse: Librairie Droz, 2022, French ed.
- 18 Dec 2012
- First Look
First Look: December 18
pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access to its potentially... View Details
Keywords: Carmen Nobel
- 05 Aug 2008
- First Look
First Look: August 5, 2008
/b01/en/common/item_detail.jhtml?id=808167 The Coartem Challenge (A) Harvard Business School Case 706-037 In November 2005, Novartis, a major global pharmaceutical firm, is reviewing its Coartem program, an ambitious attempt to deliver... View Details
Keywords: Martha Lagace
- 03 Feb 2015
- First Look
First Look: February 3
architecture, including business- and technology-related aspects. We apply our methodology to data gathered in a large pharmaceutical firm. We show that this methodology helps to identify layers in the firm's architecture associated with... View Details
Keywords: Sean Silverthorne
- 07 Feb 2012
- First Look
First Look: February 7
commitment of a European pharmaceutical company, Novo Nordisk, to integrated reporting. Novo Nordisk is one of the pioneers of integrated reporting, which emerged out of its commitment to a "triple bottom line approach to managing... View Details
Keywords: Sean Silverthorne
- 01 Sep 2012
- News
What’s the Big Idea?
international divisions. “Goldman Sachs in New York is different from Goldman Sachs in Asia,” he observes, adding that the same is true for conglomerates operating in industries as different as pharmaceuticals and aircraft engines.... View Details
- April 1984
- Supplement
Johnson & Johnson (A): Philosophy & Culture, James Burke, Video
By: Francis Aguilar
James Burke, chairman and CEO of Johnson & Johnson, discusses the company's philosophy and culture, with particular emphasis on the significance of the Credo. View Details
Keywords: Organizational Culture; Values and Beliefs; Mission and Purpose; Management Teams; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Aguilar, Francis. "Johnson & Johnson (A): Philosophy & Culture, James Burke, Video." Harvard Business School Video Supplement 884-525, April 1984.
- 29 Jan 2013
- First Look
First Look: Jan. 29
facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its... View Details
Keywords: Sean Silverthorne
- 18 Nov 2014
- First Look
First Look: November 18
were the strengths and challenges facing this model? How would the model evolve in the future? And how would new, similar collaboration models surfacing at other major pharmaceutical companies pose a threat to the Pfizer model? Purchase... View Details
Keywords: Sean Silverthorne